{"id":"https://openalex.org/W7225824925","doi":"https://doi.org/10.3389/fneur.2026.1958018","title":"Postmarketing safety profile of eculizumab for neuromyelitis optica spectrum disorder: a disproportionality and time-to-onset analysis","display_name":"Postmarketing safety profile of eculizumab for neuromyelitis optica spectrum disorder: a disproportionality and time-to-onset analysis","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225824925","doi":"https://doi.org/10.3389/fneur.2026.1958018"},"language":"en","primary_location":{"id":"doi:10.3389/fneur.2026.1958018","doi":"https://doi.org/10.3389/fneur.2026.1958018","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1958018","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1958018/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1958018/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100331068","display_name":"Xiang Li","orcid":"https://orcid.org/0000-0003-1465-6708","observed_orcids":["https://orcid.org/0000-0003-1465-6708","https://orcid.org/0000-0002-5945-159X"]},"institutions":[{"id":"https://openalex.org/I14243506","display_name":"Hong Kong Polytechnic University","ror":"https://ror.org/0030zas98","country_code":"HK","type":"education","lineage":["https://openalex.org/I14243506"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Xiang Li","raw_affiliation_strings":["School of Optometry, The Hong Kong Polytechnic University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Optometry, The Hong Kong Polytechnic University","institution_ids":["https://openalex.org/I14243506"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102525187","display_name":"Minqing Cai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191208505","display_name":"Xiamen University","ror":"https://ror.org/00mcjh785","country_code":"CN","type":"education","lineage":["https://openalex.org/I191208505"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Minqing Cai","raw_affiliation_strings":["Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University","institution_ids":["https://openalex.org/I191208505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161430928","display_name":"Ruize Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143187","display_name":"First Affiliated Hospital of University of South China","ror":"https://ror.org/049z3cb60","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210143187"]},{"id":"https://openalex.org/I91935597","display_name":"University of South China","ror":"https://ror.org/03mqfn238","country_code":"CN","type":"education","lineage":["https://openalex.org/I91935597"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ruize Shi","raw_affiliation_strings":["Department of Ophthalmology, The First Affiliated Hospital, Hengyang Medical School, University of South China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, The First Affiliated Hospital, Hengyang Medical School, University of South China","institution_ids":["https://openalex.org/I4210143187","https://openalex.org/I91935597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161473189","display_name":"Zhijie Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhijie Zhang","raw_affiliation_strings":["Department of Ophthalmology, Shizong County People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Shizong County People\u2019s Hospital","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5136610913","display_name":"Shaoying Tan","orcid":"https://orcid.org/0000-0001-9997-7396","observed_orcids":["https://orcid.org/0000-0001-9997-7396"]},"institutions":[{"id":"https://openalex.org/I14243506","display_name":"Hong Kong Polytechnic University","ror":"https://ror.org/0030zas98","country_code":"HK","type":"education","lineage":["https://openalex.org/I14243506"]}],"countries":["HK"],"is_corresponding":true,"raw_author_name":"Shaoying Tan","raw_affiliation_strings":["Center for Eye and Vision Research (CEVR)","Research Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University","School of Optometry, The Hong Kong Polytechnic University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Eye and Vision Research (CEVR)","institution_ids":[]},{"raw_affiliation_string":"Research Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University","institution_ids":["https://openalex.org/I14243506"]},{"raw_affiliation_string":"School of Optometry, The Hong Kong Polytechnic University","institution_ids":["https://openalex.org/I14243506"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5136610913"],"corresponding_institution_ids":["https://openalex.org/I14243506"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8996999859809875},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.8881000280380249},{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.7358999848365784},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6913999915122986},{"id":"https://openalex.org/C2781137167","wikidata":"https://www.wikidata.org/wiki/Q611458","display_name":"Neuromyelitis optica","level":3,"score":0.4787999987602234},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.46790000796318054},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.43709999322891235},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.4032999873161316},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3686999976634979},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36730000376701355},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.36640000343322754},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.34610000252723694},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2989000082015991},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.29429998993873596},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.27959999442100525},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.26759999990463257},{"id":"https://openalex.org/C2776015282","wikidata":"https://www.wikidata.org/wiki/Q644318","display_name":"Vasculitis","level":3,"score":0.2628999948501587}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fneur.2026.1958018","doi":"https://doi.org/10.3389/fneur.2026.1958018","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1958018","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1958018/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fneur.2026.1958018","doi":"https://doi.org/10.3389/fneur.2026.1958018","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1958018","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1958018/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225824925.pdf","grobid_xml":"https://content.openalex.org/works/W7225824925.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1988100739","https://openalex.org/W1989454703","https://openalex.org/W2004265876","https://openalex.org/W2010452704","https://openalex.org/W2015487160","https://openalex.org/W2054338937","https://openalex.org/W2064716383","https://openalex.org/W2086049425","https://openalex.org/W2092102896","https://openalex.org/W2112430000","https://openalex.org/W2129229339","https://openalex.org/W2137053633","https://openalex.org/W2144469764","https://openalex.org/W2208791667","https://openalex.org/W2549864631","https://openalex.org/W2730107276","https://openalex.org/W2744554341","https://openalex.org/W2801554786","https://openalex.org/W2807617864","https://openalex.org/W2810721991","https://openalex.org/W2896045114","https://openalex.org/W2914487156","https://openalex.org/W2943416206","https://openalex.org/W2949643330","https://openalex.org/W3003751458","https://openalex.org/W3088822708","https://openalex.org/W3101100514","https://openalex.org/W3124662713","https://openalex.org/W3129249804","https://openalex.org/W3133785312","https://openalex.org/W3177228831","https://openalex.org/W3198316871","https://openalex.org/W4229025055","https://openalex.org/W4292148185","https://openalex.org/W4364382725","https://openalex.org/W4382787427","https://openalex.org/W4391104850","https://openalex.org/W4400380865","https://openalex.org/W4402905611","https://openalex.org/W4403020556","https://openalex.org/W4406034476","https://openalex.org/W4406988129","https://openalex.org/W4407599030","https://openalex.org/W4412105607","https://openalex.org/W4412737130","https://openalex.org/W4414487806","https://openalex.org/W4416020422","https://openalex.org/W4416661977","https://openalex.org/W7123409609","https://openalex.org/W7140628429","https://openalex.org/W7164154319"],"related_works":[],"abstract_inverted_index":{"Background":[0],"To":[1],"evaluate":[2],"adverse":[3,154],"events":[4,233],"associated":[5],"with":[6,11,90,136,217,253],"eculizumab":[7,44,74],"treatment":[8,240],"in":[9,88,251],"patients":[10,252],"neuromyelitis":[12],"optica":[13],"spectrum":[14],"disorder":[15],"(NMOSD)":[16],"using":[17,116],"the":[18,48,52,58,76,91,95,106,117,181,214,221,232],"US":[19],"Food":[20,97],"and":[21,36,70,84,98,111,122,146,167,174,176,197,229,259],"Drug":[22,99],"Administration":[23],"Adverse":[24],"Event":[25],"Reporting":[26],"System":[27],"(FAERS),":[28],"thereby":[29],"providing":[30],"evidence":[31,247],"for":[32,248],"clinical":[33,143,205,258],"risk":[34],"identification":[35],"long-term":[37],"safety":[38,249],"monitoring.":[39],"Methods":[40],"Reports":[41],"related":[42],"to":[43,134,224,264],"were":[45,65,80,86,103,157,164,187,201,211],"extracted":[46],"from":[47,51,67],"FAERS":[49],"database":[50],"first":[53,59],"quarter":[54,60],"of":[55,61,152,231],"2004":[56],"through":[57],"2026.":[62],"NMOSD":[63,254],"cases":[64],"identified":[66],"reported":[68],"indications,":[69],"only":[71],"reports":[72,156,216],"listing":[73],"as":[75,203],"primary":[77],"suspect":[78],"drug":[79],"included.":[81,158],"Data":[82],"cleaning":[83],"deduplication":[85],"performed":[87],"accordance":[89],"procedures":[92],"recommended":[93],"by":[94,142],"U.S.":[96],"Administration.":[100],"Disproportionality":[101],"analyses":[102],"conducted":[104],"at":[105,137],"system":[107,172],"organ":[108],"class":[109],"(SOC)":[110],"preferred":[112],"term":[113],"(PT)":[114],"levels":[115],"reporting":[118],"odds":[119],"ratio":[120],"(ROR)":[121],"Bayesian":[123],"confidence":[124],"propagation":[125],"neural":[126],"network":[127],"(BCPNN)":[128],"methods.":[129],"Signal":[130],"detection":[131],"was":[132,226],"restricted":[133],"PTs":[135],"least":[138],"three":[139],"reports,":[140],"followed":[141],"priority":[144],"assessment":[145],"time-to-onset":[147,219],"analysis.":[148],"Results":[149],"A":[150],"total":[151],"954":[153],"event":[155],"The":[159],"most":[160],"frequently":[161],"involved":[162],"SOCs":[163],"general":[165],"disorders":[166],"administration":[168],"site":[169],"conditions,":[170],"nervous":[171],"disorders,":[173],"musculoskeletal":[175,194],"connective":[177],"tissue":[178],"disorders.":[179],"At":[180],"PT":[182],"level,":[183],"27":[184],"positive":[185],"signals":[186,200,210],"identified,":[188],"primarily":[189],"including":[190],"fatigue,":[191],"headache,":[192],"pain,":[193],"stiffness,":[195],"dizziness,":[196],"paresthesia.":[198],"Twelve":[199],"classified":[202],"moderate":[204],"priority,":[206],"whereas":[207],"no":[208],"strong-priority":[209],"identified.":[212],"Among":[213],"152":[215],"complete":[218],"information,":[220],"median":[222],"time":[223],"onset":[225],"356":[227],"days,":[228],"50.0%":[230],"occurred":[234],"more":[235],"than":[236],"360":[237],"days":[238],"after":[239],"initiation.":[241],"Conclusion":[242],"These":[243],"findings":[244],"provide":[245],"new":[246],"monitoring":[250],"receiving":[255],"eculizumab.":[256],"Further":[257],"basic":[260],"research":[261],"is":[262],"warranted":[263],"validate":[265],"these":[266],"findings.":[267]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}